The Lancet Gastroenterology & Hepatology Journal Cover August 1st 2017

Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial In the C-SURFER study, therapy with the all-...

Full description

Bibliographic Details

Main Author:	Andrew Selby
Format:	Default Image
Published:	2019
Subjects:	Other creative arts and writing not elsewhere classified Lancet Gastroenterology Hepatology Studies in the Creative Arts and Writing not elsewhere classified
Online Access:	https://hdl.handle.net/2134/27683
Tags:	Add Tag No Tags, Be the first to tag this record!